Bass, Berry & Sims attorney Jeff Davis will be speaking on a CLE Webinar titled “340B After Genesis and Other Recent Developments: Definition of Patient, Registration of Child Sites, and Contract Pharmacy Use”.
This webinar will cover key evolving issues of importance to 340B covered entities, as well as other companies operating in the 340B space, including the current status of the definition of a 340B-eligible “patient,” ongoing litigation related to the use of 340B drugs in hospital “child sites” and through contract pharmacies, and recent legislative developments at the federal and state levels.
This is a 60-minute video webinar that will be available on-demand.
For more information, click here.